Combined radiochemotherapy with paclitaxel in the treatment of malignant glioma

Strahlentherapie und Onkologie

Volumn 178, Issue 9, 2002, Pages 486-490

  Schuck, Andreas ^a   Müller, Stefan B ^a   Köhler, Andreas ^b   Könemann, Stefan ^a   Wienstroer, Marlies ^a   Mosler, Christina ^a   Rübe, Claudia E ^c   Wassmann, Hansdetlef ^a   Willich, Normann ^a   Rübe, Christian ^c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Department of Radiotherapy of the District Hospital Gütersloh ^*  (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Malignant glioma; Paclitaxel; Radiochemotherapy

Indexed keywords

DEXAMETHASONE; DIPHENHYDRAMINE; PACLITAXEL; RANITIDINE;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; RADIATION DOSAGE; RADIATION-SENSITIZING AGENTS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0036729495     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-002-1007-7     Document Type: Article

References (30)

1. Patterns of failure following CT-based 3-D irradiation for malignant glioma
2. Cytotoxicity of Taxol in vitro against human and rat malignant brain tumors
3. Salvage chemotherapy with paclitaxel for recurrent primary brain tumors
4. A phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants
5. Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: A randomized double-blind study
6. Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors
7. Weekly, outpatient Paclitaxel and concurrent cranial irradiation in adults with brain tumors: Preliminary results and promising directions
8. Acute toxicity and changes in quality of life during combined radio-chemotherapy of glioblastomas with topotecan
9. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionising irradiation
10. Taxol and ionizing radiation: Interaction and mechanisms
11. Paclitaxel (Taxol) concentrations in brain tumor tissue
12. Prognostic factors in glioblastoma multiforme. 10 Years experience of a single institution
13. A study of concurrent radiochemotherapy with paclitaxel in glioblastoma multiforme
14. The risk of venous thromboembolism is increased throughout the course of malignant glioma: An evidence based review
15. Tumor oxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse
16. A randomized comparison of misonidazol sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: Final reports of an RTOG study
17. Survival and prognosis of patients with astrocytoma with atypical or anaplastic features
18. A review of current and future treatment strategies for malignant astrocytomas in adults
19. A phase II study of paclitaxel in chemonaive patients with recurrent high-grade glioma
20. Phase II study of paclitaxel in patients with recurrent malignant glioma
21. Der fehler zweiter art und seine bedeutung bei der beurteilung von resultaten. Qualitätsanalyse der zeitschrift "strahlentherapie und onkologie"
22. Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme
23. Kombinationswirkung von Paclitaxel und ionisierender Strahlung
24. Anforderungen an die patientenaufklärung am beispiel der strahlentherapie
25. Krankheitsspezifische belastungen von tumorpatienten zu beginn einer strahlentherapie
26. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma: Brain Tumor Cooperative Group Trial 8001
27. Radiotherapy for high grade gliomas
28. Taxol sensitizes human astrocytoma cells to radiation
29. Radiation and high-dose metronidazole in supratentorial glioblastomas
30. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery